Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Mass Consortium Corp., Dana-Farber, NCI, Partek, Mitsubishi, Genomatix, BioDiscovery, EBI

Agilent Partners, Mass Consortium to Co-Develop Metabolomics Search Software
Agilent Technologies said in late August that it is partnering with Mass Consortium Corp. to develop desktop software that will automate searches for the publicly available METLIN metabolite database.
METLIN, hosted by the Scripps Research Institute, contains information on 216 LC/MS analyses, 4,096 metabolites, 123 metabolite MS/MS spectra.
Agilent said that its metabolomics customers will receive a software package that will enable customization of the METLIN database, including the addition of proprietary compounds and related data. The software package will be compatible with Agilent’s MassHunter Workstation software and GeneSpring MS software.
“Agilent is committed to advancing the field of metabolomics with our growing portfolio of GC/MS, LC/MS, software tools and applications,” said Taia Ergueta, general manager of Agilent’s mass spectrometry business, in a statement.
The software package is expected to be available early next year to customers who purchase products from Agilent’s chromatography and mass spectrometry metabolomics tools.

Dana-Farber Computational Biology Dept. Uses FlashDisk OpenSAN for Cluster
Data storage firm Winchester Systems said this week that the Dana Farber Cancer Institute's Department of Computational Biology has built a high-performance computing and storage infrastructure using its FlashDisk OpenSAN products.
Forty computer nodes connect to the SAN, Winchester said. The system includes an FX-608e RAID head with 8 TB of storage in four enclosures each with 16 disk drives of 146 GB.
Financial details were not provided.

NCI Takes Site-Wide Licenses to Partek Genomics Suite
Partek said this week that the National Cancer Institute has purchased site-wide licenses to its Partek Genomics Suite.
All NCI researchers will have access to the statistical and visual data analysis software package under the agreement.
Partek Genomics Suite enables detection and display of alternative splice events, exon-level and copy number alterations, and mapping sites of protein/DNA interaction in chromatin immunoprecipitation (ChIP)-on-chip experiments.
Financial terms of the agreement were not disclosed.

Mitsubishi Space Software To Sell Waban Software in Japan
Mitsubishi Space Software will sell Waban Software’s Waban Explorer PGx and Waban SCE in Japan, the companies said this week.
Financial terms of the deal were not disclosed.
In a statement, Himanshu Oberoi, president of Waban, said the deal grew out of the global growth of clinical pharmacogenomics, biomarker development and personalized medicine and the increased demand in Asia for Waban products.
Waban Explorer PGx provides a 21 CFR11-compliant platform for integrating multiple data sources “and enables exploring, browsing, querying and running analyses using multiple analysis tools,” the company said.
Waban SCE offers a controlled environment for managing analyses and reporting in a 21 CFR11-compliant manner with a full audit trail and traceability, Waban added.

Genomatix Wins $1.6M Contract for RNAi Product Development, Signs Distributor in China
Genomatix Software said this week that it has won a $1.6-million BioChance research contract from the German Federal Ministry of Education and Research to support development of RNA interference products.
Separately, the company announced that it had signed Beijing ZGZ Science and Technology Development to distribute its products in China.
Beijing ZGZ will distribute Genomatix’s entire line of informatics products, including those for integrated microarray analysis and the MatBase transcription factor database.
ZGZ is Genomatix’s first distributor in China and its third in Asia.
The two-year BioChance contract will enable Genomatix to “pursue research in RNAi-mediated regulatory networks and to further expand its competence and product line” in the field, the company said in a statement.
Genomatix will work with academic research partners on the project, including the Ludwig-Maximilians University in Munich and the German Cancer Research Center in Heidelberg, which will carry out the wet lab experimental part of the research.

BioDiscovery Integrates GeneDirector with EBI's ArrayExpress
BioDiscovery has integrated its GeneDirector data-management system with the European Bioinformatics Institute’s ArrayExpress microarray data repository, the company said this week.
The integration aims at simplifying the task of submitting data to EBI's public repository while preparing for print publication, BioDiscovery said.
GeneDirector manages microarray data, including array and sample tracking, sample processing, hybridization, and image-analysis tracking. The company said the system can integrate data from any array technology.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.